Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives

Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological cancers. Despite improvements in medical treatments, the prognosis for EOC remains poor, and there is an urgent need for new therapeutic strategies. Immune checkpoint inhibitors (CPIs) have dramatically improved surviv...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostics (Basel)
Main Authors: Borella, Fulvio, Ghisoni, Eleonora, Giannone, Gaia, Cosma, Stefano, Benedetto, Chiara, Valabrega, Giorgio, Katsaros, Dionyssios
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7151145/
https://ncbi.nlm.nih.gov/pubmed/32156035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10030146
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items